Annual EBITDA
-$83.98 M
-$53.35 M-174.15%
December 31, 2023
Summary
- As of February 7, 2025, APGE annual EBITDA is -$83.98 million, with the most recent change of -$53.35 million (-174.15%) on December 31, 2023.
- During the last 3 years, APGE annual EBITDA has fallen by -$53.35 million (-174.15%).
- APGE annual EBITDA is now -174.15% below its all-time high of -$30.64 million, reached on December 31, 2022.
Performance
APGE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$58.64 M
-$14.55 M-33.01%
September 30, 2024
Summary
- As of February 7, 2025, APGE quarterly EBITDA is -$58.64 million, with the most recent change of -$14.55 million (-33.01%) on September 30, 2024.
- Over the past year, APGE quarterly EBITDA has dropped by -$30.50 million (-108.40%).
- APGE quarterly EBITDA is now -3128.96% below its all-time high of -$1.82 million, reached on June 1, 2022.
Performance
APGE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$169.01 M
-$34.33 M-25.49%
September 30, 2024
Summary
- As of February 7, 2025, APGE TTM EBITDA is -$169.01 million, with the most recent change of -$34.33 million (-25.49%) on September 30, 2024.
- Over the past year, APGE TTM EBITDA has dropped by -$85.03 million (-101.24%).
- APGE TTM EBITDA is now -9206.88% below its all-time high of -$1.82 million, reached on June 1, 2022.
Performance
APGE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
APGE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -174.2% | -108.4% | -101.2% |
| 3 y3 years | -174.2% | -210.5% | -201.5% |
| 5 y5 years | -174.2% | -210.5% | -201.5% |
APGE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -174.2% | at low | -3129.0% | at low | -9206.9% | at low |
| 5 y | 5-year | -174.2% | at low | -3129.0% | at low | -9206.9% | at low |
| alltime | all time | -174.2% | at low | -3129.0% | at low | -9206.9% | at low |
Apogee Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$58.64 M(+33.0%) | -$169.01 M(+25.5%) |
| Jun 2024 | - | -$44.09 M(+15.6%) | -$134.68 M(+23.0%) |
| Mar 2024 | - | -$38.15 M(+35.6%) | -$109.48 M(+30.4%) |
| Dec 2023 | -$83.98 M | -$28.14 M(+15.8%) | -$83.98 M(+20.2%) |
| Sep 2023 | - | -$24.30 M(+28.7%) | -$69.86 M(+24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$18.89 M(+49.2%) | -$56.06 M(+43.8%) |
| Mar 2023 | - | -$12.66 M(-9.6%) | -$38.99 M(+48.1%) |
| Dec 2022 | -$30.64 M | -$14.01 M(+33.3%) | -$26.33 M(+113.7%) |
| Sep 2022 | - | -$10.51 M(+478.6%) | -$12.32 M(+578.6%) |
| Jun 2022 | - | -$1.82 M | -$1.82 M |
FAQ
- What is Apogee Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Apogee Therapeutics?
- What is Apogee Therapeutics annual EBITDA year-on-year change?
- What is Apogee Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly EBITDA year-on-year change?
- What is Apogee Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Apogee Therapeutics?
- What is Apogee Therapeutics TTM EBITDA year-on-year change?
What is Apogee Therapeutics annual EBITDA?
The current annual EBITDA of APGE is -$83.98 M
What is the all time high annual EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high annual EBITDA is -$30.64 M
What is Apogee Therapeutics annual EBITDA year-on-year change?
Over the past year, APGE annual EBITDA has changed by -$53.35 M (-174.15%)
What is Apogee Therapeutics quarterly EBITDA?
The current quarterly EBITDA of APGE is -$58.64 M
What is the all time high quarterly EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly EBITDA is -$1.82 M
What is Apogee Therapeutics quarterly EBITDA year-on-year change?
Over the past year, APGE quarterly EBITDA has changed by -$30.50 M (-108.40%)
What is Apogee Therapeutics TTM EBITDA?
The current TTM EBITDA of APGE is -$169.01 M
What is the all time high TTM EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM EBITDA is -$1.82 M
What is Apogee Therapeutics TTM EBITDA year-on-year change?
Over the past year, APGE TTM EBITDA has changed by -$85.03 M (-101.24%)